Cyclobenzaprine

Award Notice Posted

Solicitation number
VA797P12R0003
Agency
Awarded
to Golden State Medical Supply, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
VA797P-12-C-0026 Federal IDV award
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

Added: Jan 11, 2012 3:07 pm Modified: May 04, 2012 10:02 amTrack Changes NATIONAL CONTRACT ANNOUNCEMENT



CONTRACTOR: Golden State Medical Supply

CONTRACT ADMINISTRATOR: Sonia Espinoza

TELEPHONE NUMBER: 805-477-9866 x207

CONTRACT NUMBER: VA797P-12-C-0026



ACTION: New Award



EFFECTIVE PERIOD: 05/15/2012 – 05/14/2013



ELIGIBLE PARTICIPANTS:

Department of Veterans Affairs (VA), Captain James A. Lovell Federal Healthcare Center (FHCC)

All Ordering Activities under the Department of Defense (DOD) Pharmaceuticals Prime Vendor, All Indian Health Service Facilities (IHS), and All Option 2 State Veterans Homes, and Bureau of Prisons (BOP)





NDC PRODUCT DESCRIPTION PACKAGE SIZE PRICE

60429-0052-01 Cyclobenzaprine HCL (10MG) TAB 100s $1.45

60429-0052-10 Cyclobenzaprine HCL (10MG) TAB 1000s $12.62



NOTES:



1. This is an Indefinite Delivery, Requirements-Type contract awarded under competitive procedures in support of VA’s Pharmaceutical National Standardization Program and mandatory for the eligible participants listed above. The products on this contract are available through the Pharmaceutical Prime Vendor Program only.



2. (Applicable to VA Only) Only personnel designated as Ordering Officers by the National Acquisition Center (NAC), and/or warranted contracting staff are authorized to place orders through VA’s Pharmaceutical Prime Vendor contract.



3. Automatic substitution procedures are applicable for the above products.

For more information regarding this notice, please contact Youlanda Duggar at (708) 786 -4943 or youlanda.duggar@va.gov.

Update #1 ·

Added: Jan 11, 2012 3:07 pm The VA National Acquisition Center intends to issue Request for Proposal (RFP) VA-797-12-R-0003 under the competitive negotiated procedures for Carbidopa, Cyclobenzaprine, and Loperamide. Please see the item and estimated annual usage listed below. The estimated annual usage includes Department of Veterans Affairs (VA), Department of Defense (DOD), Indian Health Services (IHS), and Federal Healthcare Center (FHCC). The contract period will be for the base year and two option years. The contract item will be distributed through VA and DOD respective Pharmaceutical Prime Vendors. Award will be made in the aggregate for line items 1A, 1B, 2A, 2B or 2C, 3A and 3B for the base year and two options. To be considered for award, offerors are required to submit a proposal for the base year and two option periods. Proposals that fail to include prices for the base year and the two, one-year options on which an offer is made will be rejected and receive no further consideration.



Each drug in this solicitation represents separate requirements for the purpose of Federal Acquisition

Regulation Clause 52.217-9, “Option to Extend the Term of the Contract†and FAR Clause 52.233-3,

“Service of Protest.†A separate determination on the exercise of subsequent contract options will be

made individually for each of the three drugs.



Products offered must be FDA compliant. Offerors must state the exact (name that appears on label) by which the drug will be supplied and products proposed must have unique 11-digit NDC number. Tablets and capsules must be compatible with automated dispensing units (Baxter ATC Canister, OptiFill, etc). If the offeror is not a manufacturer, a signed agreement between the offeror and the manufacturer must be submitted with the offer. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone request for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to: youlanda.duggar@va.gov



DESCRIPTION PKG. SIZE (BOTTLES) TOTAL EST. ANNUAL USAGE



CARBIDOPA 25MG/LEVODOPA 100MG TAB SA 100s 41,185

CARBIDOPA 50MG/LEVODOPA 200MG TAB SA 100s 74,408



CYCLOBENZAPRINE HCL 10MG TAB 100s 51,699

CYCLOBENZAPRINE HCL 10MG TAB 500s 168,956

OR

CYCLOBENZAPRINE HCL 10MG TAB 1000s 84,478



LOPERAMIDE HCL 2MG CAP 100s 28,866

LOPERAMIDE HCL 2MG CAP 500s 31,622

Files

File Type Posted
VA797P-12-C-0026-000.doc DOC document
VA797P-12-R-0003-000.docx DOCX document

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login